PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α
Berinstein, N., Smyth, L., Pennell, N., Weerasinghe, R., Cheung, M., Imrie, K., Spaner, D., Chodirker, L., Piliotis, E., Milliken, V., Boudreau, A., Zhang, L., Reis, M., Chesney, A., Good, D., Ghorab,Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_120
Date:
June, 2017
File:
PDF, 247 KB
english, 2017